STOCK TITAN

AiXin Life Intl (AIXN) 10-Q Filings

AIXN OTC

Here are the 10-Q quarterly reports from AiXin Life Intl Inc (AIXN) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow AIXN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIXN filings page.

Rhea-AI Summary

Aixin Life International (AIXN) reported another weak quarter for the three months ended September 30, 2025. Net revenue fell to $301,979 from $936,406 a year earlier, as direct sales and pharmacy revenue declined sharply, while hotel and manufacturing segments also generated lower sales. The company posted a quarterly net loss of $340,461, though this was narrower than the prior-year loss of $546,186.

For the first nine months of 2025, revenue dropped to $1.16 million from $3.12 million, and the net loss widened slightly to $1.41 million. Operating cash outflow increased to $1.77 million, partly funded by $3.28 million of advances from related parties, leaving cash at only $19,113 and a working capital deficit of $6.77 million. Total liabilities of $9.20 million, including $5.46 million due to related parties, exceed total assets of $3.37 million, resulting in a stockholders’ deficit of $5.82 million. Management discloses that these conditions raise substantial doubt about the company’s ability to continue as a going concern and plans to rely on cost controls, higher-margin products, related-party loans, and potential equity offerings.